Lantern, a specialty care platform, has secured $30 million in funding, which is able to assist it increase throughout employers and well being plans, the corporate introduced on Thursday.
Dallas, Texas-based Lantern directs members of well being plans and self-insured employers to the top-performing native suppliers for surgical procedure, most cancers remedy, infusion care or different medical wants. It serves greater than 1,000 shoppers within the U.S.
The $30 million elevate was led by Morgan Well being, a JPMorgan Chase enterprise unit centered on employer-sponsored healthcare, in addition to Echo Well being Ventures, a strategic funding platform that invests on behalf of a number of Blues well being plans.
Morgan Well being selected to put money into Lantern as a result of it’s addressing a serious contributor of prices for employers.
“Specialty care is a main driver of well being care prices and contributes to the double-digit value escalation that almost all employers are experiencing. On high of that, customers are more and more pissed off with the shortage of instruments to navigate their circumstances and want to their employers to ease this burden,” stated Dan Mendelson, CEO of Morgan Well being, in an announcement. “Lantern’s capacity to enhance outcomes and decrease prices helps a more healthy, extra engaged workforce – and we’re dedicated to accelerating their affect.”
In keeping with John Zutter, CEO of Lantern, the corporate is already worthwhile, so this elevate is “opportunistic.” Will probably be used to reinvest in three areas: know-how, go-to-market and partnerships.
“On the know-how entrance, we see a major alternative to include rising applied sciences into each our operations and our member and supplier experiences,” Zutter advised MedCity Information. “We have already got a number of use instances deployed which can be delivering significant worth throughout the enterprise. … We’re persevering with to see exponential progress throughout employers and we’re deepening relationships with well being plans, constructing on a powerful observe file of decreasing the price of specialty care whereas enhancing outcomes and experiences.”
He added that the corporate is seeing a shift in how well being plans have interaction with fashions like Lantern, with 50% of the corporate’s new gross sales for 2026 linked to well being plan companions, a rise from about 10% final 12 months.
Trying forward, Lantern is concentrated on price containment for shoppers, advancing its most cancers providing and leveraging rising applied sciences, Zutter stated.
“We stay centered on making certain the most important variety of members within the U.S. have entry to inexpensive specialty care,” he stated. “We consider one of the simplest ways to advance that mission is thru continued funding in our product, and thru advancing vital partnership relationships with well being plans and different channel companions.”
Different specialty care corporations embody Carrum Well being and Transcarent.
Photograph: StockFinland, Getty Pictures
